Elite Pharmaceuticals, Inc. (ELTP)
0.2762
-0.01
(-2.99%)
USD |
OTCM |
Sep 02, 16:00
Elite Pharmaceuticals Total Return Level : 0.2762 for Sept. 2, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 02, 2026 | 0.2762 |
| September 01, 2026 | 0.2847 |
| August 31, 2026 | 0.2875 |
| August 28, 2026 | 0.2888 |
| August 27, 2026 | 0.288 |
| August 26, 2026 | 0.285 |
| August 25, 2026 | 0.286 |
| August 24, 2026 | 0.2891 |
| August 21, 2026 | 0.295 |
| August 20, 2026 | 0.2974 |
| August 19, 2026 | 0.303 |
| August 18, 2026 | 0.3035 |
| August 17, 2026 | 0.308 |
| August 14, 2026 | 0.31 |
| August 13, 2026 | 0.3585 |
| August 12, 2026 | 0.36 |
| August 11, 2026 | 0.361 |
| August 10, 2026 | 0.3601 |
| August 07, 2026 | 0.361 |
| August 06, 2026 | 0.3577 |
| August 05, 2026 | 0.3609 |
| August 04, 2026 | 0.3649 |
| August 03, 2026 | 0.3716 |
| July 31, 2026 | 0.3789 |
| July 30, 2026 | 0.3727 |
| Date | Value |
|---|---|
| July 29, 2026 | 0.3716 |
| July 28, 2026 | 0.375 |
| July 27, 2026 | 0.385 |
| July 24, 2026 | 0.3875 |
| July 23, 2026 | 0.375 |
| July 22, 2026 | 0.373 |
| July 21, 2026 | 0.379 |
| July 20, 2026 | 0.385 |
| July 17, 2026 | 0.3882 |
| July 16, 2026 | 0.399 |
| July 15, 2026 | 0.3749 |
| July 14, 2026 | 0.3719 |
| July 13, 2026 | 0.365 |
| July 10, 2026 | 0.3687 |
| July 09, 2026 | 0.3667 |
| July 08, 2026 | 0.369 |
| July 07, 2026 | 0.3635 |
| July 06, 2026 | 0.36 |
| July 02, 2026 | 0.341 |
| July 01, 2026 | 0.3597 |
| June 30, 2026 | 0.3651 |
| June 29, 2026 | 0.395 |
| June 26, 2026 | 0.3951 |
| June 25, 2026 | 0.385 |
| June 24, 2026 | 0.3699 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Nektar Therapeutics | 72.74 |
| Daré Bioscience, Inc. | 0.74 |
| Eton Pharmaceuticals, Inc. | 61.96 |
| ANI Pharmaceuticals, Inc. | 73.06 |
| Corcept Therapeutics, Inc. | 110.43 |